Drug
Revumenib
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Full Blood Count Decreased | 42 | 49.8 | 52.3 | signal |
| 2 | Full Blood Count Abnormal | 20 | 45.4 | 46.4 | signal |
| 3 | Transfusion | 18 | 40.9 | 41.8 | signal |
| 4 | Platelet Count Decreased | 139 | 31.2 | 36.9 | signal |
| 5 | Hospice Care | 12 | 29.1 | 29.5 | signal |
| 6 | Taste Disorder | 24 | 28.6 | 29.4 | signal |
| 7 | Electrocardiogram Qt Prolonged | 42 | 27.9 | 29.3 | signal |
| 8 | Laboratory Test Abnormal | 30 | 24.3 | 25.2 | signal |
| 9 | Cytopenia | 12 | 24.0 | 24.3 | signal |
| 10 | Neutrophil Count Decreased | 37 | 21.8 | 22.7 | signal |
| 11 | Leukaemia | 7 | 17.7 | 17.9 | signal |
| 12 | Red Blood Cell Count Decreased | 17 | 14.2 | 14.4 | signal |
| 13 | White Blood Cell Count Decreased | 64 | 14.1 | 15.1 | signal |
| 14 | Sluggishness | 5 | 11.8 | 11.8 | signal |
| 15 | Acute Myeloid Leukaemia | 7 | 10.7 | 10.8 | signal |
| 16 | Product Dose Omission Issue | 103 | 8.6 | 9.7 | signal |
| 17 | Product Packaging Quantity Issue | 3 | 6.6 | 6.6 | signal |
| 18 | Myelosuppression | 6 | 4.2 | 4.2 | signal |